| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.12 | 2e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 3e-05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |